Cargando…
MicroRNAs as the critical regulators of autophagy-mediated cisplatin response in tumor cells
Chemotherapy is one of the most common therapeutic methods in advanced and metastatic tumors. Cisplatin (CDDP) is considered as one of the main first-line chemotherapy drugs in solid tumors. However, there is a high rate of CDDP resistance in cancer patients. Multi-drug resistance (MDR) as one of th...
Autores principales: | Tolue Ghasaban, Faezeh, Maharati, Amirhosein, Akhlaghipour, Iman, Moghbeli, Meysam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127417/ https://www.ncbi.nlm.nih.gov/pubmed/37098542 http://dx.doi.org/10.1186/s12935-023-02925-7 |
Ejemplares similares
-
MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers
por: Tolue Ghasaban, Faezeh, et al.
Publicado: (2023) -
Role of the long non-coding RNAs in regulation of Gemcitabine response in tumor cells
por: Maharati, Amirhosein, et al.
Publicado: (2023) -
Role of microRNAs in regulation of doxorubicin and paclitaxel responses in lung tumor cells
por: Maharati, Amirhosein, et al.
Publicado: (2023) -
Molecular mechanisms of microRNA-216a during tumor progression
por: Hamidi, Amir Abbas, et al.
Publicado: (2023) -
MicroRNAs as the critical regulators of tyrosine kinase inhibitors resistance in lung tumor cells
por: Maharati, Amirhosein, et al.
Publicado: (2022)